CKD (6407) Q2 2027 earnings summary

Executive summary

• H1 FY2027 revenue was ¥108,052 million, up 48.7% YoY; operating profit was ¥18,828 million, up 139.3%, and net income was ¥13,066 million, up 143.0%.

• Strong semiconductor-related demand, particularly for Components and generative-AI applications, drove growth; Automatic Machinery sales declined.

Financial highlights

• H1 ordinary profit was ¥19,024 million, up 140.8% YoY; comprehensive income was ¥21,912 million, up 192.8%.

• Gross profit rose to ¥34,535 million from ¥21,189 million; SG&A increased to ¥15,707 million from ¥13,322 million.

• At September 30, 2026, total assets were ¥261,848 million, liabilities ¥89,600 million and net assets ¥172,214 million.

• H1 operating cash flow was ¥7,793 million; investing and financing cash outflows were ¥2,426 million and ¥4,213 million, respectively.

Outlook and guidance

• FY2027 forecast raised to revenue ¥218,000 million, operating and ordinary profit ¥38,500 million each, and net income ¥26,500 million; forecast EPS is ¥396.48.

• Forecast growth is 38.1% for revenue, 96.0% for operating profit and 95.2% for net income; operating margin is 17.7%, up 2.9 points vs. prior forecast.

• The upgrade reflects Components demand exceeding expectations; robust conditions are anticipated through Q3 and beyond. Forecast assumes ¥151/USD and ¥22/RMB.

• FY2027 ROE forecast was raised to 16.1% from 11.9%.